APD
42
-2
NTRS
37
-3
FRT
46
-2
DLTR
46
-5
MDLZ
67
-2
MCD
57
-5
GPC
47
-3
LOW
36
-13
NTAP
31
-5
DD
33
-4
WU
42
-6
FOXA
63
-3
PG
64
-4
SE
72
-3
HON
53
-7
RHI
23
-5
VIX
60
16
PAYX
53
-3
MTCH
22
-13
FAST
42
-4
APD
42
-2
NTRS
37
-3
FRT
46
-2
DLTR
46
-5
MDLZ
67
-2
MCD
57
-5
GPC
47
-3
LOW
36
-13
NTAP
31
-5
DD
33
-4
WU
42
-6
FOXA
63
-3
PG
64
-4
SE
72
-3
HON
53
-7
RHI
23
-5
VIX
60
16
PAYX
53
-3
MTCH
22
-13
FAST
42
-4
Financhill
Back

Kaival Brands Innovations Group Vs. Alnylam Pharmaceuticals Industry Stock Comparison

Sell
16

KAVL
Kaival Brands Innovations Group

Last Price:
$0.59
Seasonality Move:
374.31%
Sell
43

ALNY
Alnylam Pharmaceuticals

Last Price:
$268.29
Seasonality Move:
7.6%
Sell
16
Kaival Brands Innovations Group (KAVL) is a Sell

Is Kaival Brands Innovations Group a Buy, Sell or Hold?

  • The current Kaival Brands Innovations Group [KAVL] share price is $0.56. The Score for KAVL is 16, which is 68% below its historic median score of 50, and infers higher risk than normal.
  • KAVL is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
43
Alnylam Pharmaceuticals (ALNY) is a Sell

Is Alnylam Pharmaceuticals a Buy, Sell or Hold?

  • The current Alnylam Pharmaceuticals [ALNY] share price is $268.46. The Score for ALNY is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
  • ALNY is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

KAVL Stock Price Chart

What is Kaival Brands Innovations Group's stock price today?

  • The Kaival Brands Innovations Group share price today is $0.56
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and KAVL is experiencing selling pressure, which indicates risk of future bearish movement.

ALNY Stock Price Chart

What is Alnylam Pharmaceuticals's stock price today?

  • The Alnylam Pharmaceuticals share price today is $268.46
    The current trend is moderately bullish and ALNY is experiencing slight buying pressure.

KAVL Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.1 Sell
Relative Strength Index (14 RSI): 28.99 Sell
Chaikin Money Flow: -60034 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.58 - 0.78) Sell
Bollinger Bands (100): (0.68 - 1.14) Sell

ALNY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 5.41 Buy
Relative Strength Index (14 RSI): 55.64 Buy
Chaikin Money Flow: 78938 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (238.82 - 268.04) Buy
Bollinger Bands (100): (240.65 - 270.25) Buy

KAVL Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.57 Sell
20-day SMA: 0.64 Sell
50-day SMA: 0.94 Sell
200-day SMA: 1.02 Sell
8-day EMA: 0.58 Sell
20-day EMA: 0.66 Sell
50-day EMA: 0.81 Sell
200-day EMA: 1.56 Sell

ALNY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 271.33 Sell
20-day SMA: 255.41 Buy
50-day SMA: 259.88 Buy
200-day SMA: 253.94 Buy
8-day EMA: 268.64 Sell
20-day EMA: 261.32 Buy
50-day EMA: 257.88 Buy
200-day EMA: 244.57 Buy

Kaival Brands Innovations Group Earnings Growth & KAVL Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Alnylam Pharmaceuticals Earnings Growth & ALNY Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.91 per share, an increase next quarter of $0.05 per share, an increase this year of $1.08 per share, and an increase next year of $2.75 per share.

Kaival Brands Innovations Group Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Alnylam Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):